Cold urticaria is a rare condition where exposure to cold temperatures triggers an allergic-like skin reaction. Managing this condition involves preventing symptoms through lifestyle adjustments and using medications that calm the body’s response to cold. While there is no cure, proper treatment can help people with cold urticaria live more comfortably and reduce the risk of serious reactions.

Managing a Rare Cold-Triggered Condition

Cold urticaria is not just about feeling uncomfortable in chilly weather. For people living with this condition, a simple swim in cool water, holding a cold drink, or stepping outside on a winter day can trigger an immune system reaction that produces itchy hives, swelling, and in some cases, more severe symptoms. The main goal of treatment is to control these reactions and prevent them from interfering with daily life or causing dangerous complications.

Treatment for cold urticaria depends on how severe the symptoms are and how often they occur. Some people experience only mild skin reactions that last an hour or two, while others may develop whole-body responses that require emergency care. Because the condition varies so much from person to person, doctors tailor treatment plans to each individual’s needs and the specific triggers they face.^[1]

The two main forms of cold urticaria — acquired and familial — also influence treatment approaches. Acquired cold urticaria, which appears without any family history, typically causes symptoms within minutes of cold exposure and resolves within a couple of hours. Familial cold urticaria, which is inherited, may take much longer to appear (sometimes up to 48 hours after exposure) and can last for a day or two. Understanding which type a person has helps doctors choose the most appropriate treatment strategy.^[1]

Standard medical treatments are available and widely used, but researchers are also studying new therapies that may offer better relief for people who don’t respond well to existing options. This ongoing research is important because cold urticaria can significantly impact quality of life, limiting work, school, outdoor activities, and even what people can eat or drink.

Standard Treatment Approaches

The foundation of cold urticaria treatment is avoiding cold triggers whenever possible. This means dressing warmly in layers, protecting exposed skin, staying away from cold water activities, and being cautious with cold foods and beverages. However, since avoiding cold entirely is often impossible, medications play a central role in managing symptoms.^[2]

Antihistamines are the first-line treatment for cold urticaria. These medications work by blocking histamine, a chemical that the immune system releases in response to cold exposure. Histamine is what causes the itching, redness, swelling, and hives that characterize cold urticaria. By preventing histamine from binding to cells in the skin and other tissues, antihistamines can reduce or prevent these uncomfortable symptoms.^[1]

Doctors typically start with non-sedating, second-generation antihistamines. These medications are preferred because they don’t cause drowsiness like older antihistamines do. Common examples include loratadine (found in brands like Claritin), cetirizine (found in Zyrtec), and desloratadine (found in Clarinex). Some of these are available without a prescription, while others require a doctor’s order.^[9]

For many people with cold urticaria, standard doses of antihistamines don’t provide enough relief. In these cases, doctors may increase the dose to up to four times the normal amount. This higher dosing approach is supported by clinical guidelines and has been shown to be safe and more effective for chronic urticaria conditions. Studies suggest that approximately 67 percent of patients respond well to antihistamines alone.^[12]

The way antihistamines are used can vary based on a person’s lifestyle. Some people take them daily to maintain constant protection, especially during colder months. Others take them before planned exposure to cold, such as before going outdoors in winter or before swimming. The timing and frequency depend on how often symptoms occur and what triggers are most problematic.^[9]

Other medications that have shown some benefit include cyproheptadine, doxepin, and ketotifen. These are different types of antihistamines or medications with antihistamine-like effects. They may be tried when standard antihistamines don’t work well enough. Each has its own side effect profile, so doctors consider individual patient factors when prescribing them.^[12]

Oral corticosteroids, such as prednisone, are sometimes used for short periods when symptoms are severe. However, studies have shown that corticosteroids are generally not effective for long-term management of cold urticaria. They also come with significant side effects when used regularly, including weight gain, mood changes, weakened bones, and increased infection risk. For these reasons, they are not recommended as a routine treatment.^[12]

Antibiotics are not used to treat cold urticaria itself, but they may be prescribed if doctors suspect that an underlying infection is contributing to the condition. Some cases of cold urticaria are associated with viral infections like mononucleosis or chickenpox, or other infectious diseases. Treating these infections may help improve urticaria symptoms.^[1]

Another approach that some specialists use is called desensitization or cold tolerance induction. This involves gradually exposing the skin to increasingly cold temperatures over time, with the goal of training the body to become less reactive. For example, a person might start with daily lukewarm showers that gradually become cooler over weeks or months. This method requires careful medical supervision and should not be attempted without guidance, as it carries risks of triggering severe reactions.^[5]

The duration of treatment varies widely. Some people experience spontaneous improvement or complete resolution of cold urticaria after several years. Studies suggest that about 50 percent of patients improve within approximately five years, with some studies showing 14 percent of adults have resolution at five years and 43 percent at ten years. However, others live with the condition for much longer and require ongoing medication.^[8][12]

Treatment Options Being Studied in Clinical Research

For people whose cold urticaria doesn’t respond well to antihistamines, even at high doses, researchers have been investigating additional treatment options. These newer therapies target different aspects of the immune system’s reaction to cold.

One of the most promising treatments is omalizumab, sold under the brand name Xolair. This is a biologic medication — a type of drug made from living cells that targets a specific part of the immune system. Omalizumab is a humanized monoclonal antibody that works by binding to IgE antibodies in the blood. IgE antibodies play a key role in allergic reactions, including the reaction that occurs in cold urticaria.^[9]

Omalizumab was originally approved for treating asthma and later for chronic spontaneous urticaria (hives without an identifiable trigger). Although it is not specifically approved for cold urticaria in many countries, doctors have been using it off-label for patients who don’t respond to antihistamines. This off-label use is supported by several clinical studies and case reports showing that it can be effective.^[15]

The medication is given by injection, typically once every four weeks. The standard starting dose is often 150 milligrams, but this can be increased to 300 milligrams if the response is inadequate. The injections are usually given in the lower abdomen by a healthcare professional, though some patients learn to self-administer them at home. Because omalizumab suppresses part of the immune system, regular monitoring is important.^[7]

A retrospective study of 19 patients with cold urticaria treated with omalizumab showed promising results. The research found that omalizumab effectively controlled symptoms and prevented further episodes of anaphylaxis in these patients. Some studies included in systematic reviews reported that up to 100 percent of patients treated with omalizumab achieved symptom control, though results varied across different studies. This variation suggests that while omalizumab can be very effective for some patients, it may not work for everyone.^[15][12]

Researchers have found that omalizumab may be particularly helpful for patients with chronic cold urticaria who have a history of anaphylaxis. By reducing the frequency and severity of reactions, the medication can significantly improve quality of life and allow people to participate more fully in daily activities without constant fear of a dangerous reaction.^[15]

Another medication that has been studied is anakinra, known by the brand name Kineret. This medication is used to treat familial cold urticaria, particularly a condition called familial cold autoinflammatory syndrome (FCAS), which is a genetic form that is different from typical acquired cold urticaria. Anakinra is an immunosuppressant that blocks a protein called interleukin-1, which plays a role in inflammation. While it has shown effectiveness for FCAS, it requires daily injections, which can be burdensome for patients.^[7]

A similar medication called canakinumab (brand name Ilaris) has also been used for familial cold urticaria. This is also a monoclonal antibody that targets the same inflammatory pathway as anakinra but requires less frequent dosing. These medications represent an important advance for patients with the inherited form of cold urticaria.^[7]

Some clinical research has explored the use of leukotriene antagonists, medications commonly used for asthma and allergies. These drugs work by blocking leukotrienes, chemicals in the body that contribute to inflammation and allergic reactions. While there have been reports of successful treatment with leukotriene antagonists in cold urticaria, the evidence is still limited and more research is needed to understand their role.^[12]

Cyclosporine is an immunosuppressant medication that has been tried in some cases of cold urticaria that don’t respond to other treatments. This drug works by dampening the entire immune system response. While it can be effective, it comes with significant side effects including kidney problems, high blood pressure, and increased infection risk. For this reason, it is typically reserved for severe cases that haven’t responded to safer options.^[12]

Another medication that has been reported in case studies is dapsone, an antibiotic with anti-inflammatory properties. Some patients have experienced improvement with dapsone, though this is not a standard treatment and more research is needed to understand when it might be helpful.^[12]

Researchers have also investigated a synthetic hormone called danazol for treating cold urticaria. This medication affects hormone levels and immune function. While some case reports suggest it may help certain patients, it has significant hormonal side effects and is rarely used today.^[12]

Clinical trials continue to explore new treatment options for cold urticaria. These trials typically go through three phases. Phase I trials focus on safety, testing the medication in a small number of people to see if it causes harmful side effects. Phase II trials look at whether the treatment actually works and what dose is most effective. Phase III trials compare the new treatment to standard options in larger groups of patients to determine if it offers real advantages.

Patients interested in participating in clinical trials for cold urticaria may find opportunities through allergy and immunology specialists at academic medical centers. These trials can offer access to cutting-edge treatments, though participants must understand that experimental therapies carry unknown risks and may not prove effective.

Most common treatment methods

• Antihistamine medications
  • Non-sedating second-generation antihistamines like loratadine, cetirizine, and desloratadine are the first-line treatment, often used in doses up to four times higher than standard
  • Other antihistamine-type medications such as cyproheptadine, doxepin, and ketotifen may be tried when standard options don’t provide adequate relief
  • Medications can be taken daily for continuous protection or before planned cold exposure depending on individual needs
• Biologic therapy
  • Omalizumab (Xolair), a monoclonal antibody that targets IgE, is used for patients who don’t respond to antihistamines, given by injection typically every four weeks
  • Anakinra (Kineret) and canakinumab (Ilaris) are used specifically for familial cold autoinflammatory syndrome, blocking inflammatory pathways
• Cold avoidance strategies
  • Dressing in multiple warm layers and protecting exposed skin when outdoors in cold weather
  • Avoiding cold water activities or taking precautions such as wearing protective clothing and having supervision
  • Being cautious with cold foods and beverages, warming them before consumption if they trigger symptoms
• Emergency medications
  • Epinephrine autoinjectors are prescribed for patients with history of severe reactions to provide immediate treatment for anaphylaxis
  • Short courses of oral corticosteroids may be used for severe symptom flares, though they are not effective for long-term management
• Immunosuppressive medications
  • Cyclosporine may be considered for severe cases that don’t respond to other treatments, though it requires careful monitoring due to side effects
  • Other medications like leukotriene antagonists and dapsone have been tried in some cases with varying results
• Desensitization therapy
  • Gradual exposure to increasingly cold temperatures under medical supervision to train the body to become less reactive
  • This approach requires careful monitoring and should only be attempted with guidance from an allergy specialist